Bukwang Pharmaceutical Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Jae-Young Lee
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 18.5yrs |
Recent management updates
Recent updates
Bukwang Pharmaceutical (KRX:003000) Has Debt But No Earnings; Should You Worry?
Nov 13
Is Bukwang Pharmaceutical (KRX:003000) Weighed On By Its Debt Load?
May 22Investors In Bukwang Pharmaceutical Co., Ltd. (KRX:003000) Should Consider This, First
Apr 03Did Bukwang Pharmaceutical's (KRX:003000) Share Price Deserve to Gain 71%?
Mar 08Is Bukwang Pharmaceutical (KRX:003000) A Risky Investment?
Feb 10How Much Of Bukwang Pharmaceutical Co., Ltd. (KRX:003000) Do Insiders Own?
Jan 14Does It Make Sense To Buy Bukwang Pharmaceutical Co., Ltd. (KRX:003000) For Its Yield?
Dec 19Did You Miss Bukwang Pharmaceutical's (KRX:003000) 90% Share Price Gain?
Nov 23CEO
Jae-Young Lee
less than a year
Tenure
Jae-Young Lee is Chief Executive Officer of Bukwang Pharmaceutical Co. Ltd. from 2024.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & Director | no data | no data | no data | |
| Managing Director and Director | 18.5yrs | no data | no data | |
| Senior Managing Director | no data | no data | no data | |
| Chairperson | 18.5yrs | no data | 10.3% ₩ 32.2b | |
| Vice Chairman | 18.5yrs | no data | no data | |
| Representative Director | no data | no data | no data | |
| Independent Outside Director | no data | no data | no data | |
| Independent Outside Director | no data | no data | no data | |
| Independent Outside Director | no data | no data | no data |
18.5yrs
Average Tenure
70yo
Average Age
Experienced Board: A003000's board of directors are seasoned and experienced ( 18.5 years average tenure).